{{Rsnum
|rsid=7193230
|Gene=CNTNAP4
|Chromosome=16
|position=76284645
|Orientation=plus
|GMAF=0.2185
|Gene_s=CNTNAP4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 56.2 | 39.1 | 4.7
| HCB | 53.3 | 33.3 | 13.3
| JPT | 61.4 | 31.8 | 6.8
| YRI | 84.1 | 15.9 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 53.3 | 33.3 | 13.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=5E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | FTDNA}}